Oxybutynin
Product Images NDC 50090-5352

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Oxybutynin (NDC 50090-5352). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 01

F8631e88 7755 4b29 848c 7ef657463803 01
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 02

F8631e88 7755 4b29 848c 7ef657463803 02
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 03

F8631e88 7755 4b29 848c 7ef657463803 03
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 04

F8631e88 7755 4b29 848c 7ef657463803 04
The text provides limited information on Oxybutynin chloride extended-release tablets and a placebo. The numbers -40, 20, and 40 may indicate dosage or time intervals, but without additional context, it is unclear. Further information is necessary to generate a useful description.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 05

F8631e88 7755 4b29 848c 7ef657463803 05
Oxybutynin chloride extended-release tablets are a medication used to treat symptoms associated with an overactive bladder. The given text seems to contain some formatting or chart representation of data that is not readable and hence, not available for description.*
FDA Label Image

F8631e88 7755 4b29 848c 7ef657463803 06

F8631e88 7755 4b29 848c 7ef657463803 06
FDA Label Image

Label Image (Lbl500905352)

Label Image (Lbl500905352)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.